Where does Molex CVS Dabendorf GMBH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Molex CVS Dabendorf GMBH ranks #32,537 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Molex CVS Dabendorf GMBH hold?

Molex CVS Dabendorf GMBH holds 8 US utility patents granted between 2020 and 2023, spanning 8 technology areas.

What is Molex CVS Dabendorf GMBH's Innovation Score?

Molex CVS Dabendorf GMBH has an Innovation Score of 46.5 out of 100 (top 21% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Molex CVS Dabendorf GMBH focus on?

Molex CVS Dabendorf GMBH's top technology area is H04B (Transmission) with 7 patents, ranking #1,036 of 3,909 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Molex CVS Dabendorf GMBH's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Molex CVS Dabendorf GMBH.

What does claim depth mean for Molex CVS Dabendorf GMBH's patents?

Molex CVS Dabendorf GMBH's patents average 14.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Molex CVS Dabendorf GMBH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Molex CVS Dabendorf GMBH

USPTO PatentsView assignee record - 8 granted patents across 8 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04B (Transmission).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Molex ranks #32,537 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 8 technology areas.

#32,537
of 49,997 US assignees by volume: Top 21%
by Innovation Score (46.5/100): 14.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R32537 · Foreign Corporation #32,537 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 8 grants
MID-PACK #32,537/49,997
PHOTO-FINISH Modern Flames
CPC-NARROW H04B · 8 areas
INNOV-PAR 46.5/100
CLAIMS-RICH 14.9 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2023 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Modern Flames, LLC. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Molex’s 46.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (16%) Velocity 20.0 pts (43%) Breadth 10.0 pts (22%) Claim depth 8.9 pts (19%)

Qualcomm Incorporated · highest

85
Molex CVS Dabendorf · this assignee

47
3D Lighting… · lowest

7

What this shows Molex's Innovation Score is 46.5/100 (top 21% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Molex?

Each dot is one of Molex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Molex’s own 14.9 claims/patent is ABOVE the 11.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Molex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Molex's grants concentrate

Molex CVS Dabendorf GMBH is a focused PatentsView assignee: 8 CPC subclasses with 87.5% of grants classified under H04B (Transmission). Peak complete grant year is 2022 (4 grants) versus a trough of 1 in 2020. By volume, Molex sits between Modern Flames, LLC. and Mori Seiki Co., Ltd..

Molex's three-year grant acceleration

Molex CVS Dabendorf GMBH shows 6 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Modern Flames

8
Modicum

8
Moerae Matrix

8
Molabo

8
Mologic

8
Molteni & C S P A

8
MON Bento

8
Mori Seiki

8
Molex CVS Dabendo… ◀

8

What this shows Molex holds 8 patents at rank #32,458, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Molex

By rank, the assignees closest to #32,458 in granted patent volume.

Leaders in H04B (Transmission)

Other assignees with the most granted patents in Molex's primary technology class.

Molex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 21% higher than 79% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Molex CVS Dabendorf GMBH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	12.5%
2021	1	12.5%
2022	4	50.0%
2023	2	25.0%

Which technologies does Molex CVS Dabendorf GMBH patent most?

H04B - Transmission 7

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 2

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 2

H01Q - Antennas, i.e. Radio Aerials 1

H02M - Apparatus FOR Conversion Between AC AND AC, Between AC AND DC, OR Between DC AND DC, AND FOR USE With Mains OR Similar Power Supply SYSTEMS; Conversion OF DC OR AC Input Power Into Surge Output POWER; Control OR Regulation Thereof 1

Y02D - Climate Change Mitigation Technologies IN Information AND Communication Technologies [ICT], I.E. Information AND Communication Technologies Aiming AT THE Reduction OF Their OWN Energy USE 1

H04W - Wireless Communication Networks 1

H03F - Amplifiers 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Molex CVS Dabendorf GMBH's patent record in context - here's where to go next.

Molex CVS Dabendorf GMBH's lead technology class is H04B (Transmission), 87.5% of its portfolio - see every assignee active in that class. Explore H04B
Ranked #32,537 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Molex CVS Dabendorf GMBH against Modern Flames, LLC., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 46.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.